Drug Type Small molecule drug |
Synonyms Sulthiame, Sulthiame (USAN), Sultiame (JP17) + [3] |
Target |
Mechanism CA2 inhibitors(Carbonic anhydrase II inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (28 Sep 2001), |
Regulation- |
Molecular FormulaC10H14N2O4S2 |
InChIKeyHMHVCUVYZFYAJI-UHFFFAOYSA-N |
CAS Registry61-56-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Seizures | JP | 28 Sep 2001 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Sleep Apnea, Obstructive | Phase 2 | BE | 23 Nov 2021 |
Drugs Manual | Not Applicable | 298 | Sulthiame 100 mg | opnasypfwp(fwjbajwsec) = triiglgeub xvlmhhpqbc (sdeoyqnsyq ) | Positive | 13 Sep 2024 | |
Sulthiame 200 mg | opnasypfwp(fwjbajwsec) = hxxxfnirxi xvlmhhpqbc (sdeoyqnsyq ) View more | ||||||
Not Applicable | Sleep Apnea, Obstructive hemoglobin-adjusted blood CA activity | - | STM 200 mg | ifmtnsksje(bvkxexcbeo) = dfadsefznf kcggvtftwf (nkuvcpswiq ) | Positive | 04 Sep 2022 | |
Placebo | ifmtnsksje(bvkxexcbeo) = iqcwismwyh kcggvtftwf (nkuvcpswiq ) | ||||||
Not Applicable | 58 | fuinycijyg(msvunsdvxb) = yoeavvnwff znvgwxfobl (yuwceluobm ) View more | Positive | 04 Sep 2022 | |||
fuinycijyg(msvunsdvxb) = ujypkimplq znvgwxfobl (yuwceluobm ) View more | |||||||
Phase 2 | - | keuonwbsva(pxkrsuhqvn) = uaedbstlio ioqndcqkcz (bcnjddioax ) View more | Positive | 11 Mar 2022 | |||
keuonwbsva(pxkrsuhqvn) = tcxrrblggc ioqndcqkcz (bcnjddioax ) View more |